In March 2018, the United Kingdom, along with the rest of the world, were shocked by news of the poisoning of an ex-Russian spy. Less than three months later, paramedics were called to a flat in Amesbury, England, after a local couple were exposed to the very same agent used earlier in the year. (1) Subsequent confirmation that the substance used in these attacks belonged to the Novichok class of nerve agents has turned a spotlight on what are considered amongst the world's deadliest chemical weapons. This article aims to explore Novichok and its effects on the human body, given the high likelihood of future usage of these agents.
The name Novichok means "newcomer" in Russian, highlighting the fact that its development marked a breakthrough in chemical weapons. (2) Novichok is a series of organophosphate nerve agents. Nerve agents are organic substances which disrupt the body's normal nervous communication to muscles and organs. (1) Novichok was developed as part of the Russian classified nerve agent program named FOLIANT over a period of two decades from 1971. (3) It has never been used on the battlefield as its use is forbidden under the terms of the Chemical Weapons Convention of 1993. It is believed that Novichok was developed as the Soviet Union's response to false information that the USA was producing its own nerve agents during the Cold War. (2, 4) The effects of Novichok, like all nerve agents, are due to the blocking of acetylcholinesterase (AChE) which catalyses the breakdown of acetylcholine (ACh). (4) ACh is a neurotransmitter found in vesicles of pre-synaptic neurons at neuromuscular junctions. As an action potential passes down a neuron, the depolarisation causes an influx of calcium ions, triggering exocytosis of ACh from the pre-synaptic neuron and diffusion across the synaptic cleft. ACh then binds onto nicotinic ACh receptors (nAChRs) on the post-synaptic membrane, causing sodium ion channels to open. An influx of sodium ions through the post-synaptic membrane causes depolarisation. The subsequent action potential results in contraction of a muscle or release of a hormone. Once the action has been produced, the enzyme AChE catabolises the neurotransmitter to allow the muscle or organ to relax. (See Figure 1) 
Figure 1 -Events at a neuromuscular junction
Novichok is a non-competitive inhibitor of AChE, accounting for its irreversible inactivation. (5) The nerve agent causes a build-up of ACh, preventing further re-depolarisation of the post-synaptic membrane, so that impulse transmission ceases. This results in muscles remaining in their contracted states. Symptoms of poisoning appear within seconds of exposure and death occurs rapidly by asphyxiation or cardiac arrest due to failure of contraction of the diaphragm and heart. Whilst most nerve agents affect the central nervous system exclusively, Novichok also affects the peripheral nervous system, leading to peripheral weakness and paraesthesia. (6) Exposure to Novichok is generally by inhalation, although absorption may also occur percutaneously. (7) Early symptoms include rhinorrhea, chest tightness, and miosis. Later stages involve involuntary salivation, loss of continence and abdominal pain. This is followed by myoclonic jerks and status epilepticus. (6) If treatment is not initiated timely, death will ensue. Most of the literature on Novichok is based on testimonies from the scientists involved in developing the agent. As it is still a relatively new chemical which few people have been exposed to, our understanding of the symptomology and treatment are limited. Andrei Zheleznyakov, a scientist involved in the Novichok's development, was accidentally exposed to the agent in 1987. He was unconscious for 10 days postexposure. Zheleznyakov then began to suffer from "chronic weakness in his arms, a toxic hepatitis that gave rise to cirrhosis of the liver, epilepsy, spells of severe depression, and an inability to read or concentrate that left him totally disabled and unable to work". Other antidotes include pralidoxime and diazepam. Pralidoxime binds to AChE causing the phosphate group of the nerve agent to be displaced. The poison/antidote complex then unbinds from the active site, thus regenerating the fully functional AChE enzyme. (10) It is possible to survive a Novichok attack; however, victims may be left with permanent disabilities such as chronic muscle weakness and reduced cognitive ability.
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The British Student Doctor Volume 3, No. 1 (2019) by Novichok; of which three have died. Today, news of such chemical attacks is rapidly circulated and information about the poison and the risk of exposure can become misconstrued by the public. Therefore, it is increasingly important that clinicians can be called upon to lend their expertise in the education and treatment of attacks caused by dangerous chemical weapons.
